      |
Latest Headlines
Roche breast cancer drug gets FDA priority review
Vigorous exercise upregulates genes that protect against prostate CA progression
Novel drug prolongs survival in late-stage prostate cancer
Ovarian cancer screening popular despite guidelines
FDA staff unsure about new use for Amgen's Xgeva
NEWS PROVIDED BY 
VIEW ALL NEWSNEWS PROVIDED BY
